IDH2 and central nervous system cancer: Aggressive gliomas, which include GBM, harbor wild-type IDH1 and IDH2 genes (IDHwt), whereas gliomas with better prognosis carry mutated IDH1 and IDH2 genes (IDHmut) [4].